medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2012, Number 04

<< Back Next >>

Ginecol Obstet Mex 2012; 80 (04)

Intrahepatic cholestasis of pregnancy: Review

Medina LJM, Jáuregui MRA, Medina CN, Medina CD

Language: Spanish
References: 65
Page: 285-294
PDF size: 219.47 Kb.


ABSTRACT

The etiology of intrahepatic cholestasis of pregnancy includes genetic and environmental factors. Bile acids elevation in maternal and fetal blood is the main fact of its physiopathology, causing maternal itching and high perinatal morbidity and mortality. High levels of maternal blood bile acids are diagnostic. Best treatment is ursodeoxycolic acid and clearly it produces amelioration of bile acid levels and itching, but it is uncertain if it reduces perinatal morbidity and mortality. As far as fetal death is one of sudden onset, probably due to acute hypoxia, tests to evaluate and predict fetal condition are useless. Pregnancy interruption at 36-37 gestation weeks is the best strategy for lowering fetal death incidence. The purpose of this work is to achieve an actualized literature review on this disease.


REFERENCES

  1. Kroumpouzos G, Cohen L. Specific dermatosis of pregnancy: an evidence-based systematic review. A Journal Obstet Gynecol 2003;188:1083-1092.

  2. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15:2049-2066.

  3. Caughey AB. Cholestasis of pregnancy: in need of a more rapid diagnosis. J Perinatol 2006;26:525-526.

  4. Reyes H, González MC, Ribalta H, Aburto J, et al. Prevalence of cholestasis intrahepatic of pregnancy in Chile. Ann Intern Med 1978;88:487-493.

  5. Riely AC, Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis 2004;8:167-176.

  6. Zollner G, Trauner M. Mechanisms of Cholestasis. Clin Liver Dis 2008; 12: 1-26.

  7. Alissa FT, Jaffe R, Shneider BL. Update on Progressive Familial Intrahepatic Cholestasis. J Pediatr Gastroenterol Nutr 2008;46:241-252.

  8. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Eng J Med 1998;339:1217-1226.

  9. Meier Y, Pauli-Magnus C, Zanger UM, Klein K, et al. Interindividual variability of canalicular ATP-Binding cassette (ABC)-Transporter expression in human liver. Hepatology 2006;44:62-74.

  10. Stieger B. Recent insights into the function and regulation of the bile salt export puma (ABCB11). Curr Opin Lipidiol 2009;20:176-81.

  11. Reyes H. Sex Hormones and Bile Acids in Intrahepatic Cholestasis of Pregnancy. Hepatology 2008;47(2):376-379.

  12. Meyers M, Slikker W, Pascoe G. Characterization of cholestasis induced by estradiol 17-beta-D-glucoronide in the rat. J Pharmacol Exp Ther 1980;4:87-93.

  13. Williamson C, Hems LM, Goulis DG, Walker I, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 2004;111:676-681.

  14. Leslie K, Resnikov L, Simon F, Fennessey P, Reyes H, et al. estrogens in intrahepatic cholestasis of pregnancy. Obstet Gynecol 2000;95:372-376.

  15. Doshi S, Zucker SD. Liver emergencies during pregnancy. Gastroenterol Clin N Am 2003;32:1213-1227.

  16. Rapini RP. The skin and pregnancy. En: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR. Maternal-Fetal Medicine: Principles and Practice 6th ed. New York: Saunders Elsevier, 2009;1123-1134.

  17. Brites D, Rodrigues CM, van-Zeller H, Brito A, Silva R. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. Eur J Obstet Gynecol Reprod Biol 1998;80:31-38.

  18. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol 1983;61(5):581-587.

  19. Kenyon AP, Shennan A. Obstetric Cholestasis. Fet Mat Med Rev 2009; 20(2):119-42.

  20. Heikkinen J. Effect of a standard test meal on serum bile acid levels in healthy nonpregnant and pregnant women and in patients with intrahepatic cholestasis of pregnancy. Ann Clin Res 1983;15:183-188.

  21. Milkiewicz P, Gallagher R, Chambers J, Eggington E, Weaver J, Elias E. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J Gastroenterol Hepatol 2003;18:1283-1286.

  22. Knapen MF, Peters WH, Mulder TP, Steegers EA. A marker for hepatocellular damage. Lancet 2000;355:1463-1464.

  23. Joutsiniemi T, Leino R, Timonen S, Pulkki K, Ekblad U. Hepatocellular enzyme glutathione S-transferase alpha and intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 2008;87:1280-1284.

  24. Johnson P. Studies in cholestasis of pregnancy with special reference to lipids and lipoproteins. Acta Obstet Gynecol Scand Suppl 1973;27:1-80.

  25. Nikkilä K, Riikonen S, Lindfors M, Miettinen TA. Serum squalene and noncholesterol sterols before and after delivery in normal and cholestatic pregnancy. J Lipid Res 1996;37:2687-2695.

  26. Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, et al. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol 2006;107:106-114.

  27. Eliakim M, Sadovsky E, Stein O, Shenkar YG. Recurrent cholestatic jaundice of pregnancy. Report of five cases and electron microscopic observations. Arch Intern Med 1966;117:696-705.

  28. Obstetric Cholestasis. Royal College of Obstetricians and Gynaecologists Guidelines (RCOG) 2006;43:1-12.

  29. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid mechanisms of action and clinical use in hepatbiliary disorders. J Hepatol 2001;35:134-146.

  30. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998;4:165-178.

  31. Palma J, Reyes H, Ribalta J, Iglesias J, González MC, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992;15:1043-1047.

  32. Palma J, Reyes H, Ribalta J, Hernández I, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997;1022-1028.

  33. Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995;37:580-584.

  34. Diaferia A, Nicastri PL, Tartagni M, Loizzi P, et al. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gyneacol Obstet 1996;52:133-140.

  35. Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionien in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gyenacol 1998;105:1205-1207.

  36. Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 2001;10(2):131-135.

  37. Zapata R, Sandoval L, Palma J, Hernández I, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005;25:548-555.

  38. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005;42:1399-1405.

  39. Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graca LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. Hepatol 1998;28:91-98.

  40. Mazzella G, Rizzo N, Azzaroli F, Simoni P, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001;33:504-508.

  41. Serrano MA, Brites D, Larena MG, Monte MJ, et al. Beneficial effect of ursodeoxycholic acid in alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998;28:829-839.

  42. Gorelik J, Shevchulk AI, Diakonov I, de Swiet M, Lab M, et al. Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocites. BJOG 2003;110:467-474.

  43. Hirvioja ML, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gyneacol 1992;99:109-111.

  44. Diac M, Kenyon A, Nelson-Piercy C, Girling J, Cheng F, et al. Dexamethasone in the treatment of obstetric cholestasis: a case series. J Obstet Gyneacol 2006;26:110-114.

  45. Boelsterli UA, Rakhit G, Balazs T. Modulation by S-adenosyl-L-methionine of hepatic Na+, K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis. Hepatology 1983;3:12-17.

  46. Stramentinoli G, Di Padova C, Gualano M, Rovagnati P, Galli- Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: prospective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology 1981;80:154-158.

  47. Frezza M, Centini G, Cammareri G, Le Grazie C, Di Padova C. S-adenosyl-L-methionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990;37:S122-125.

  48. Ribalta J, Reyes H, González MC, Iglesias J, Arrese M, et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 1991;13:1084-1089.

  49. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Gynecol Reprod Biol 1982;14:153-162.

  50. Lutz EE, Margolis AJ. Obstetric hepatosis: treatment with cholestyramine and interim response to steroids. Obstet Gynecol 1969;33:64-71.

  51. Sadler LC, Lane M, North R. Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obstet

  52. Warren JE, Blaylock RC, Silver RM. Plasmapheresis for the treatment of intrahepatic cholestasis of pregnancy refractory to medical treatment. Am J Obstet Gynecol 2005; 192:2088-2089.

  53. Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-Lmethionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006;34:383-391.

  54. Fisk NM, Storey GNB. Fetal outcome in obstetric cholestasis. BJOG 1988;95:1137-43.

  55. Vega J, Saez G, Smith M, Agurto M, Morris NM. Risk-factors for low-birth-weight and intrauterine growth-retardation in Chile. Rev Med Chil 1993;121:1210-1219.

  56. Glantz A, Marschall HU, Mattson L. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004;40:467-474.

  57. Medina-Lomeli JM, Medina-Castro N. Colestasis intrahepática del embarazo, un riesgo fetal impredecible: presentación de un caso y revisión de la literatura. Ginecol Obstet Mex 2000;68:486-488.

  58. Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel H-D, et al. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 2007;46:6226-6230.

  59. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, et al. Intrahepatic cholestasis of pregnancy: a retrospective casecontrol study of perinatal outcome. Am J Obstet Gynecol 1994;170:890-895.

  60. Matos A, Bernardes J, Ayres-de-Campos D, Patricio B. Antepartum fetal cerebral hemorraghe not predicted by current surveillance methods in cholestasis of pregnancy. Obstet Gynecol 1997;89:803-804.

  61. Zimmermann P, Koskinen J, Vaalamo P, Ranta T. Doppler umbilical artery velocimetry in pregnancies complicated by intrahepatic cholestasis. J Perinat Med 1991;19:351-355.

  62. Guerra F, Guzman S, Campos G. Evaluation of maternal and fetal blood flow indices in intrahepatic cholestasis of pregnancy. Rev Chil Obstet Ginecol 1994;59:17-21.

  63. Strehlow SL, Pathak V, Goodwin TM, Pérez BM, Hebrahimi M, Lee RH. The mechanical PR interval in fetuses of woman with intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2010;203(205):455.el-5.

  64. Menezes EV, Yakoob MY, Soomro T, Haws RA, Darmstadt GL, Bhutta ZA. Review of interventions reducing stillbirths: prevention and management of medical disorders and infections during pregnancy. BMC Pregnancy and Childbirth 2009;9:1186-1471.

  65. Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol 2008;25:341-345.




2020     |     www.medigraphic.com